Chromium

Chromium has been studied in 59 papers since 1992: 2 trials and 48 observational studies in people, 1 in cells, 8 reviews; 25 in the past year. The newest paper, Nov 10, 2026: “Associations of serum lead, antimony, chromium, and cobalt with hypertension prevalence among lead-exposed workers: a multi-metal cross-sectional study in Xinjiang, China”.

Intervention

59 papers study it46 more mention it22 findingsUpdated

PubChemChEBIMeSH

6 new papers in 30 daysSee all 105 papers on chromium

At a glance

Independent labs found the same change in people. 13 independent labs in 6 countries; 4 trials, none about aging, 2 with no results posted.

“The present results indicate that Cr supplementation does not improve glucose tolerance or serum lipid levels in elderly subjects with stable impaired glucose tolerance.”
Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levelsThe British journal of nutrition1992doi:10.1079/bjn19920078

1 of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 13 independent labs in 6 countries
  • 1 finding against
  • 4 trials, none about aging, 2 with no results posted
  • Funders: National Natural Science Foundation of China and others
  • Human trial2
  • Humans48
  • Cells1

Studies in people

1 study gave chromium to people and measured what changed.

What changedDesignPeopleSource

no change: Has no effect on glucose tolerance

no change: Has no effect on serum lipids

Randomized trial6 months26 people65–74 yearsOlder adults; stable impaired glucose toleranceThe British journal of nutrition, Jul 1, 1992

What did studies of chromium find?

6

Studies of chromium measured 6 outcomes, among them type 2 diabetes, biological age and estimated glomerular filtration rate.

Type 2 diabetes

no changein humans1

1 study
  1. Chromium was not clearly linked with type 2 diabetes in humans (FTO rs9939609 AA/AT genotypes).

    “No significant association was observed among women carrying the AA/AT genotypes.”

    HumansFTO rs9939609 AA/AT genotypesdietary intakefemales

    Genotype-specific association of dietary chromium intake with type 2 diabetes according to FTO rs9939609: a case–control study

    Scientific reports

More on Type 2 diabetes

Biological age

upin humans1

1 study
  1. Chromium is linked with higher biological age in schizophrenia patients (1.029, 95 % CI: 0.303-1.756).

    “chromium (1.029, 95 % CI: 0.303-1.756)”

    Humansin schizophrenia patientsn = 104

    Association between indoor PM2.5 components and accelerated biological aging in schizophrenia patients: Evidence from multi-omics mechanisms

    Journal of hazardous materials

More on Biological age

Estimated glomerular filtration rate

no changein humans1

1 study
  1. Chromium was not clearly linked with estimated glomerular filtration rate in humans (Percent change = 0.06 %; 95 % CI, -0.80 %, 0.95 %).

    “we did not find significant association between urinary chromium and eGFR (Percent change = 0.06 %; 95 % CI, -0.80 %, 0.95 %).”

    Humansn = 183

    Threshold effect of urinary chromium on kidney function biomarkers: Evidence from a repeated-measures study

    Ecotoxicology and environmental safety

More on Estimated glomerular filtration rate

Urinary albumin-to-creatinine ratio

upin humans1

1 study
  1. Chromium is linked with higher urinary albumin-to-creatinine ratio in humans (Percent change = 10.16 %; 95 % CI, 6.41 %, 14.06 %).

    “Urinary chromium was associated with CKD (odds ratio [OR] = 1.29; 95 % confidence interval [CI], 6.41, 14.06) and UACR (Percent change = 10.16 %; 95 % CI, 6.41 %, 14.06 %)”

    Humansn = 183

    Threshold effect of urinary chromium on kidney function biomarkers: Evidence from a repeated-measures study

    Ecotoxicology and environmental safety

More on Urinary albumin-to-creatinine ratio

Serum lipids

no changein humans1

1 study
  1. Chromium showed no clear effect on serum lipids in humans (stable impaired glucose tolerance).

    “The present results indicate that Cr supplementation does not improve glucose tolerance or serum lipid levels in elderly subjects with stable impaired glucose tolerance.”

    Human trialstable impaired glucose tolerancechromium-rich yeast160 micrograms Cr/d6 monthsn = 26

    Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels

    The British journal of nutrition

More on Serum lipids

Glucose tolerance

no changein humans1

1 study
  1. Chromium showed no clear effect on glucose tolerance in humans (stable impaired glucose tolerance).

    “The present results indicate that Cr supplementation does not improve glucose tolerance or serum lipid levels in elderly subjects with stable impaired glucose tolerance.”

    Human trialstable impaired glucose tolerancechromium-rich yeast160 micrograms Cr/d6 monthsn = 26

    Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels

    The British journal of nutrition

What is chromium linked with?

15

Studies link chromium with 15 measures, among them chronic kidney disease, hypertension prevalence and early or premature menopause.

Chronic kidney disease

upin humans2OR 1.29

2 studies
  1. Chromium is associated with chronic kidney disease in humans (occupational multi-metal exposure).

    “Li, Al, Cr, and Ni showed positive associations with CKD, whereas Zn and Se showed inverse associations.”

    Humansoccupational multi-metal exposure

    Associations of Mixed-Metal Exposure with Incident Chronic Kidney Disease in an Occupational Population: A Nested Case–Control Study

    Toxics

  2. Chromium is associated with chronic kidney disease in humans (OR = 1.29, 95% CI 6.41, 14.06).

    “Urinary chromium was associated with CKD (odds ratio [OR] = 1.29; 95 % confidence interval [CI], 6.41, 14.06)”

    Humansn = 183

    Threshold effect of urinary chromium on kidney function biomarkers: Evidence from a repeated-measures study

    Ecotoxicology and environmental safety

More on Chronic kidney disease

Hypertension prevalence

upin humans1OR 2.158

1 study
  1. Chromium is associated with hypertension prevalence in humans (Lead-exposed workers in northwestern China) (OR 2.158, 95% CI 1.064–4.440).

    “Specifically, lead, chromium, and antimony were significantly positively associated with hypertension prevalence, whereas cobalt was negatively associated with hypertension prevalence.”

    HumansLead-exposed workers in northwestern Chinan = 419

    Associations of serum lead, antimony, chromium, and cobalt with hypertension prevalence among lead-exposed workers: a multi-metal cross-sectional study in Xinjiang, China

    Frontiers in public health

More on Hypertension prevalence

Early or premature menopause

downin humans1−50% lower likelihood

1 study
  1. Chromium is associated with early or premature menopause in humans (50% lower likelihood).

    “However, the likelihood of an early or premature menopause was 50% lower among women in the fourth quartile.”

    Humansfourth quartile of chromium concentrationsfemales

    Cumulative exposure to heavy metals (chromium, copper, lead, manganese, mercury, nickel, and titanium) and age at natural menopause

    International journal of environmental health research

More on Early or premature menopause

Type 2 diabetes

downin humans1OR 0.984

1 study
  1. Chromium is associated with type 2 diabetes in humans (FTO rs9939609 TT genotype; adjusted models) (OR = 0.984, 95% CI: 0.972–0.996; p = 0.010).

    “Among women with the TT genotype, higher dietary chromium intake was significantly associated with lower odds of T2DM in all adjusted models”

    HumansFTO rs9939609 TT genotype; adjusted modelsdietary intakefemales

    Genotype-specific association of dietary chromium intake with type 2 diabetes according to FTO rs9939609: a case–control study

    Scientific reports

More on Type 2 diabetes

Breast cancer

upin humans1RR 1.07

1 study
  1. Chromium is linked with a higher risk of breast cancer in humans (residential exposure over a 10-year pre-diagnosis window) (adjusted RR 1.07, 95% CI: 1.05, 1.08).

    “Exposure to PM2.5-bound chromium (adjusted RR 1.07, 95% CI: 1.05, 1.08)”

    Humansresidential exposure over a 10-year pre-diagnosis window10-year pre-diagnosis windowfemales

    Long-term exposure to PM2.5-bound metals and female breast cancer incidence in New Mexico, USA

    Air quality, atmosphere, & health

More on Breast cancer

Cardiovascular-kidney-metabolic syndrome

downin humans1

1 study
  1. Chromium is linked with a lower risk of cardiovascular-kidney-metabolic syndrome in humans (repeated-measures cohort).

    “whereas Cr showed an inverse association (0.79, 0.60-0.97)”

    Humansrepeated-measures cohortn = 472

    Urinary metal mixtures and cardio-kidney-metabolic risk in adults from a legacy-contaminated area: Repeated-measures cohort evidence and computational validation

    Ecotoxicology and environmental safety

More on Cardiovascular-kidney-metabolic syndrome

Brachial-ankle pulse wave velocity

downin humans1

1 study
  1. Chromium is associated with brachial-ankle pulse wave velocity in humans (β = -0.041).

    “The generalized linear model (GLM) indicated that chromium (Cr) was negatively associated with baPWV (β = -0.041).”

    Humansn = 431

    The mediating role of vascular age in the association between blood metals and atherosclerosis from Manganese-exposed workers healthy cohort

    BMC public health

More on Brachial-ankle pulse wave velocity

Telomere length

upin humans1

1 study
  1. Chromium is associated with telomere length in humans.

    “In the elderly, Cr and Mn were significantly positively correlated with rTL”

    Humans

    Associations of essential trace metals with telomere length in general population: a cross-sectional study

    Scientific reports

More on Telomere length

Cognitive impairment

upin humans1OR 2.15

1 study
  1. Chromium is linked with a higher risk of cognitive impairment in males (OR 2.15, 95% CI 1.27-3.63).

    “Cr was positively associated with cognitive impairment in the male (OR 95 % CI = 2.15 (1.27, 3.63)) and 60- to 70-year-old (OR 95 % CI = 2.10 (1.24, 3.57)) groups”

    Humansin malesmalesn = 1,068

    Sex and age disparities in multi-metal mixture exposure and cognitive impairment in urban elderly individuals: The mediation effect and biological function of metabolites

    The Science of the total environment

More on Cognitive impairment

Diminished renal function

upin humans1

1 study
  1. Chromium is associated with diminished renal function in humans (midlife and elderly community without kidney disease at baseline) (p < 0.05).

    “Diminished renal function, as evaluated based on fast kidney function decline, or estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2, was positively associated with the plasma concentrations of chromium and potassium”

    Humansmidlife and elderly community without kidney disease at baselineplasman = 1,368

    Combined Exposure to Multiple Metals and Kidney Function in a Midlife and Elderly Population in China: A Prospective Cohort Study

    Toxics

All 15

Has chromium been tested in people?

0 of 4 about aging

Yes: 2 trials and 48 observational studies in people have been published, and 4 trials are registered.

In trials

Trial sponsors

Funding

1 grant since 2019

US Department of Veterans Affairs

Latest

Dec 2025: 2Jan 2026: 6Feb 2026: 1Mar 2026: 2Apr 2026: 0May 2026: 2Jun 2026: 3Jul 2026: 1Aug 2026: 5Sep 2026: 1Oct 2026: 3Nov 2026: 632 papers in 12 months

See all 105 papers on chromium